Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Jul
1
2015
Activities For sNDA and Citizen’s Petition Protected by “Safe Harbor” - Supplemental New Drug Application McDermott Will & Emery
Jul
1
2015
No Induced Infringement Where Off-Label Use of a Drug Is Not “Inevitable” McDermott Will & Emery
Jul
1
2015
American Simmental Assoc. v. Leachman Cattle of Colorado: Stay of Pending Reissue Application to Avoid Inconsistencies with Post Grant Review PGR2015-00005 Faegre Drinker
Jul
1
2015
FDA Announces Delay in Enforcing DSCSA Requirements for Dispensers McDermott Will & Emery
Jun
30
2015
FDA Provides 11th Hour Delay of Product Tracing Requirements for Pharmacies Mintz
Jun
30
2015
AstraZeneca’s Crestor® Patent is Invalidated by the Brazilian Federal Courts Michael Best & Friedrich LLP
Jun
30
2015
Teva Pharm v. ViiV Healthcare Co: Denying Joinder Where Agreement to File Consolidated Papers Was Not Obtained IPR2015-00550 Faegre Drinker
Jun
30
2015
Federal Circuit Invalidates Another Diagnostic Patent Foley & Lardner LLP
Jun
30
2015
American Simmental Association v. Leachman Cattle of Colorado, LLC: Decision on Institution of Post-Grant Review Faegre Drinker
Jun
30
2015
Examination Delay Earns Patent Term Adjustment Only In One Application Foley & Lardner LLP
Jun
29
2015
New FMLA Certification Forms Include GINA Safe Harbor Notice Holland & Hart LLP
Jun
29
2015
Jury Hits Employer With $2.2 Million Verdict For GINA Violations in Workplace Defecator Case Mintz
Jun
29
2015
Rocky Mountain High Part II: Colorado’s Highest Court Approves Employer’s Stance that Employee Toke is No Joke Mintz
Jun
26
2015
Amendment to Pennsylvania Liquor Code Allowing Direct Shipment of Wine Stark & Stark
Jun
26
2015
FDA Reports Results of Annual Crack Down on Illegal Internet Pharmacies Mintz
Jun
25
2015
Federal Circuit Strikes Final Blow To Celebrex Patent Foley & Lardner LLP
Jun
24
2015
Deadlines for FSMA Final Rules Loom -- Keep Your Eye on the FDA Armstrong Teasdale
Jun
23
2015
Colorado Supreme Court Upholds Employers’ Right to Terminate for Use of Medical Marijuana During Nonworking Hours Wilson Elser Moskowitz Edelman & Dicker LLP
Jun
23
2015
Public Statements Made by Pharmaceutical and Biotech Company Executives May Raise FDA’s Hackles if They Do Not Meet Basic Requirements for Promotional Communications Mintz
Jun
23
2015
Bottled Water Sold at Pennsylvania Stores Recalled Due to Possible E. Coli Contamination Stark & Stark
Jun
22
2015
Colorado Supreme Court Plays Debbie Downer for Medical Pot Users
Jun
22
2015
Court Again Rejects Alleged ‘Fraud on the FDA’ Theory of Implied Certification Liability McDermott Will & Emery
Jun
22
2015
FDA Releases Guidance for Food Allergen Labeling Exemptions Morgan, Lewis & Bockius LLP
Jun
22
2015
FDA Issues Draft Guidance on Factors to Consider When Making Benefit-Risk Determinations for IDEs Alert Barnes & Thornburg LLP
Jun
22
2015
California Court Upholds Emotional Distress Award Due to Unannounced Random Drug Test Jackson Lewis P.C.
Jun
22
2015
Colorado Supreme Court Okays Discharge of Medical Marijuana-Using Employee Proskauer Rose LLP
Jun
22
2015
Medical Device Update: FDA Issues Draft Guidance on Benefit-Risk Determinations for IDEs Morgan, Lewis & Bockius LLP
Jun
22
2015
Teva v. Sandoz – “Strange Brew” Boils Over Schwegman, Lundberg & Woessner, P.A.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins